人工智能驱动的临床智能平台Nephrolytics完成250万美元SAFE轮融资，推出肾病护理首个全栈代理解决方案Saya™，并在RPA 2025展示突破性成果-动脉网

Nephrolytics Closes $2.5M SAFE Round, Launches Saya™ First Full Stack Agentic Solution for Kidney Disease Care, and Showcases Breakthrough at RPA 2025

CISION 等信源发布 2025-06-25 20:00



可切换为仅中文







CHUBBUCK, Idaho

爱达荷州丘布克

，

June 25, 2025

2025年6月25日

/PRNewswire/ --

Nephrolytics, Inc.

肾分析公司

, the AI-powered clinical intelligence platform revolutionizing kidney care, today announced three major milestones: the successful close of a

，这家由人工智能驱动的临床智能平台正在彻底改变肾脏护理，今天宣布了三个重要的里程碑：成功结束了一轮

$2.5M

250万美元

SAFE round, the full deployment of its flagship platform Saya™ at Idaho Kidney Institute, and its national debut at the 2025 Renal Physicians Association (RPA) Annual Meeting in

SAFE轮融资，其旗舰平台Saya™在爱达荷肾病研究所的全面部署，以及在2025年肾科医生协会（RPA）年会上的全国首秀。

Las Vegas

拉斯维加斯

。

继续阅读

The funding round was led by forward-thinking physician investors, strategic partners and healthcare leaders committed to transforming nephrology from reactive care to precision medicine. This infusion of capital will accelerate product development, expand customer success teams, and support rapid onboarding across nephrology practices and large dialysis organizations nationwide..

本轮融资由富有远见的医生投资者、战略合作伙伴和致力于将肾病治疗从被动护理转变为精准医疗的医疗领导者领投。这笔资金的注入将加速产品开发，扩大客户成功团队，并支持在全国范围内的肾病诊所和大型透析机构快速推广。

Nephrolytics revolutionizes kidney care with the first full-stack AI platform for nephrology.

Nephrolytics 通过首个全栈式 AI 肾病学平台彻底改变了肾脏护理。

Post this

发布这个

Saya™, Nephrolytics' AI-driven clinical agent

Saya™，Nephrolytics的AI驱动临床助手

, officially launched at Idaho Kidney Institute this month. Designed by nephrologists for nephrologists, Saya™ automates SOAP note creation, streamlines clinical workflows, and delivers real-time decision support—all while pulling fragmented data from EMRs, labs, hospitals, and HIEs into one unified patient view.

，本月正式在爱达荷肾脏研究所推出。Saya™ 由肾病学家设计，专为肾病学家打造，可自动创建 SOAP 病历、简化临床工作流程，并提供实时决策支持——同时将来自电子病历、实验室、医院和健康信息交换平台的碎片化数据整合到统一的患者视图中。

The result: clinicians spend less time on paperwork and more time on what matters—patient care..

结果是：临床医生减少了花在文书工作上的时间，而将更多时间用于重要的事情——患者护理。

'The successful closing of our SAFE round is a powerful signal of trust from the investor community,' said

“我们成功完成SAFE轮融资，这是投资界对我们充满信任的有力信号，”

Fahim Rahim

法希姆·拉希姆

, MD, MBA

医学博士，工商管理硕士

, CEO and Founder of Nephrolytics. 'We're excited to scale our mission—bringing AI-powered precision nephrology to the frontlines, enhancing care quality, and alleviating the administrative burden that holds clinicians back.'

，Nephrolytics首席执行官兼创始人。“我们很高兴能够扩大我们的使命——将人工智能驱动的精准肾病学带到一线，提高护理质量，并减轻阻碍临床医生的行政负担。”

At Renal Physicians Association (RPA) 2025 Annual Meeting, Nephrolytics captured attention with a dynamic introduction of Saya™ to nephrology leaders, healthcare partners, and attendees. The overwhelming response highlighted the urgent need for smart, seamless solutions that integrate into existing workflows, improve outcomes, and combat clinician burnout..

在2025年肾内科医师协会（RPA）年会上，Nephrolytics通过向肾病学领袖、医疗合作伙伴及与会者动态介绍Saya™而吸引了广泛关注。热烈的反响凸显了对智能、无缝解决方案的迫切需求，这些方案能够整合到现有工作流程中，改善治疗效果，并缓解临床医生的职业倦怠。

'We've built electronic medical records, but in the process, lost sight of the most important word in healthcare: CARE,' said

“我们建立了电子医疗记录，但在此过程中，却忽略了医疗保健中最重要的词：关怀，”他说。

Naeem Rahim

纳伊姆·拉希姆

, MD, FASN

，医学博士，FASN

, Co-Founder and Chief Medical Officer. 'Today's EMRs are not dynamic tools for clinical decision-making, but static, archival systems—repositories of the past, not enablers of the present. Nephrolytics is leading the charge to bring them into the AI first age—offering real-time insights at the Point of Care so clinicians can make faster, smarter decisions.'.

联合创始人兼首席医疗官。“如今的电子病历并不是用于临床决策的动态工具，而是静态的、归档式的系统——是过去的存储库，而非当下的推动者。Nephrolytics 正在引领将它们带入人工智能优先的时代——在诊疗点提供实时洞察，帮助临床医生更快、更明智地做出决策。”

With momentum accelerating and partnerships forming across the country, Nephrolytics is poised to redefine the future of kidney care.

随着势头的加速和全国范围内合作伙伴关系的形成，Nephrolytics 准备重新定义肾脏护理的未来。

Media Contact:

媒体联系人:

Hasan Ayub

哈桑·阿尤布

Chief Growth Officer

首席增长官

Nephrolytics, Inc.

肾析科技公司

hasan@nephrolytics.